Breath of discovery: simple test may sniff out lung cancer
NCT ID NCT07689968
First seen Jul 08, 2026 · Last updated Jul 15, 2026 · Updated 3 times
Summary
This pilot study explores whether a breath sample collected with the VosCryo device can provide enough cellular material to help diagnose advanced lung cancer. Researchers will compare breath samples from 12 people with late-stage lung cancer and 12 healthy relatives to see if the samples can tell the difference between cancerous and non-cancerous states. If successful, this could pave the way for a simple, non-invasive breath test for lung cancer detection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- VosCryo breath sample collection device
- What this could lead to
- If successful, this could lead to a simple, non-invasive breath test to help detect lung cancer, potentially enabling earlier diagnosis.
- What could go wrong
- This is a very small pilot study with only 24 participants, so results may not be generalizable. The breath sample may not contain enough usable cells for reliable analysis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Weston Park Cancer Centre
Sheffield, South Yorkshire, S10 2SJ, United Kingdom
Contact
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart drug deliver a toxic payload directly to cancer cells?
- New support model aims to ease burden on caregivers of older lung cancer patients
- Experimental drug combo targets Hard-to-Treat lung cancer
- Can a smartphone app ease the burden of advanced lung cancer?
- Personalized T-Cell therapy takes on advanced lung cancer
- Acupuncture with a jolt: could needles shield nerves from chemo?